Six-year follow-up of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM and ENDORSE

被引：0
|
作者：
Arnold, D. L. [1 ,2 ]
Fox, R. J. [3 ]
Gold, R. [4 ]
Havrdova, E. [5 ]
Kappos, L. [6 ]
Yousry, T. [7 ]
MacManus, D. [7 ]
Zhang, R. [8 ]
Yang, M. [8 ]
Rana, J. [8 ]
机构：
[1] McGill Univ, NeuroRx Res, Montreal, PQ, Canada
[2] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[5] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic
[6] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
[7] UCL, Inst Neurol, Queen Sq Multiple Sclerosis Ctr, NMR Res Unit, London, England
[8] Biogen Inc, Cambridge, MA 02142 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P566
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [1] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Yousry, T.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    MacManus, D.
    Sheikh, S.
    Zhang, R.
    Yang, M.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 156 - 156
  • [2] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Kurukulasuriya, N. C.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 93 - 93
  • [3] MRI Outcomes at Seven Years in Relapsing-Remitting Multiple Sclerosis Patients Treated With Delayed-release Dimethyl Fumarate in DEFINE, CONFIRM, and ENDORSE
    Arnold, Douglas L.
    Fox, Robert J.
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Yousry, Tarek
    MacManus, David
    Yang, Lili
    Riester, Katherine
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [4] Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Fox, Robert J.
    Kappos, Ludwig
    Chen, Chongshu
    Parks, Becky
    Miller, Catherine
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [5] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    JOURNAL OF NEUROLOGY, 2014, 261 : S93 - S93
  • [6] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 130 - 130
  • [7] Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Xiao, J.
    Taylor, C.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 296 - 297
  • [8] Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: Integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Taylor, Catherine
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 156 - 156
  • [9] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: eight-year follow-up of an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Yang, L.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 313 - 314
  • [10] Efficacy of Delayed-release Dimethyl Fumarate at Seven-Year Follow-up in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Xiao, James
    Taylor, Catherine
    NEUROLOGY, 2017, 88
12345